Delivery Order SPE2DB22D9207-SPE2DB24FH4WL
Award Date 1/18/24
Potential Completion Date 2/8/24
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Xolair 150 mg/mL syringes. The delivery order, valued at $11,605.50, has a completion date of February 5, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) with DLA to supply pharmaceuticals and medical products to military treatment facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of 4,564,160,403 units of the pharmaceutical product Xolair 150 mg/mL syringe. This order is part of a larger indefinite delivery contract, SPE2DB24FE6SV, with DMS Pharmaceutical Group valued at up to $4,999,999 through 2025. The contract allows DLA to issue delivery orders for a broad range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 75 milligram/0.5 milliliter Xolair syringes. The delivery order, valued at $3,481.65, has a completion date of February 6, 2024. DMS Pharmaceutical Group is an established federal contractor that holds various indefinite delivery contracts with DLA to supply pharmaceuticals and medical products to military treatment facilities worldwide. This...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Xolair 150 mg/ml syringe. The $1,547.40 delivery order, which has no set-aside designation, is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply a variety of pharmaceutical and medical supplies to military treatment facilities worldwide. This...
- The Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 mg/ml syringes. The $123,792.00 delivery order has an estimated completion date of April 3, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various indefinite delivery contracts with DLA to supply a wide range of pharmaceutical and medical products to military treatment...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,189.60 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of Xolair 150 mg/ml syringes. This delivery order was issued under the DLA's Medical Supply Chain SPE2DB Indefinite Delivery Contract, a $499,999,999 single-award vehicle that enables the DLA to procure a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGE 1 ML. The delivery order, valued at $23,211.00, is part of a larger indefinite delivery contract with DLA Troop Support Medical that provides a variety of pharmaceutical and medical products to support military treatment facilities worldwide. The delivery order has a completion date of February 12, 2024. DMS...
- The Defense Logistics Agency (DLA) awarded a $27,853.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Xolair 150 mg/ml syringes. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Xolair 75 mg/0.5 ml syringes. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, valued up to $4,999,999 through 2025 that enables DLA to place orders for a broad range of pharmaceutical items to support the recurring medical supply needs...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,568.80, is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This order is placed under DMS Pharmaceutical Group's larger indefinite-delivery contract (IDC) with the DLA, valued at up to...